REFRACTORY AUTOIMMUNE DISEASES

Clinical trials for REFRACTORY AUTOIMMUNE DISEASES explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY AUTOIMMUNE DISEASES trials appear

Sign up with your email to follow new studies for REFRACTORY AUTOIMMUNE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Donor immune cells tested as potential reset for stubborn autoimmune diseases

Disease control Recruiting now

This early-stage study is testing a new treatment called BMS-986515, which uses immune cells (CAR-T cells) from healthy donors, for people with severe autoimmune diseases that haven't responded to standard treatments. The main goals are to check if the treatment is safe, what sid…

Matched conditions: REFRACTORY AUTOIMMUNE DISEASES

Phase: PHASE1 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

REFRACTORY AUTOIMMUNE DISEASES

Get alerted when new REFRACTORY AUTOIMMUNE DISEASES trials appear

Donor immune cells tested as potential reset for stubborn autoimmune diseases